Pulmonary mucormycosis in the setting of chronic obstructive pulmonary disease: A case report and review of the literature

Respiration

Volumn 69, Issue 6, 2002, Pages 560-563

  Spira, Avrum ^a   Brecher, Stephen ^b   Karlinsky, Joel ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c 111PI Vet Aff B Hlth Care Syst ^*  (United States)

Author keywords

COPD; Mucormycosis

Indexed keywords

ALENDRONIC ACID; CEFTRIAXONE; CLARITHROMYCIN; DEFEROXAMINE; DIGOXIN; DILTIAZEM; IPRATROPIUM BROMIDE; ISOSORBIDE DINITRATE; MEPREDNISONE; PREDNISONE; SALBUTAMOL; STEROID;

AGED; ARTICLE; BLOOD DISEASE; BRONCHOSCOPY; BURN; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIALYSIS; DISEASE COURSE; DOSE CALCULATION; FIBER OPTICS; FUNGUS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LUNG DISEASE; LUNG INFILTRATE; MALE; MUCORALES; MUCORMYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; TISSUE CULTURE;

AGED; BRONCHOSCOPY; FATAL OUTCOME; HUMANS; LUNG DISEASES, FUNGAL; MALE; MUCORMYCOSIS;

EID: 18744400091     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066467     Document Type: Article

References (5)

1. Tedder M, Spratt JA, Anstadt MP, et al: Pulmonary mucormycosis: Results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-1050.
2. Waldorf AR, Levitz SM, Diamond RD: In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984;150:752-760.
3. Joshi N, Caputo G, Weitekamp M, Karchmer AW: Infections in patients with diabetes mellitus. New Engl J Med 1999;341:1906-1912.
4. Lee FY, Mossad SB, Adal KA: Pulmonary mucormycosis: The last 30 years. Arch Intern Med 1999;159:1301-1309.
5. Parfrey NA: Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine (Baltimore) 1986;65:113-123.